In cell and animal models of diabetes as well as in patients with T2DM, elevated levels of circulating and endothelial inflammatory markers, such as interleukin 6 (IL-6) and vascular cell adhesion molecule 1, as well as markers of endothelial dysfunction are generally observed [28–32]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.